The Virginia General Assembly is in the midst of final considerations for a swath of bills that could come into effect as soon as July 1st. Many measures, ranging from gun control to health care, have already passed both houses and received the requisite signature from Governor Spanberger. Yet with thousands of bills being introduced this session, it is often difficult for Virginians to thoroughly understand where their state is headed on certain issues. As part of a new series — General Assembly in Action — The Jefferson Independent will provide concise coverage of recently passed bills and how they will affect everyday Virginians.
Health care remains one of the most complex issues to tackle, but it has received some of the most bipartisan support throughout the entire General Assembly. Senate Bill 669, passed unanimously by both chambers, regulates the pharmaceutical market by requiring drug distributors to use a pass-through pricing model when selling to pharmacies. Current models allow distributors to essentially hide fees when selling to pharmacies, making costs more variable for pharmacies and harder to predict for consumers. Senate Bill 630 also received bipartisan support, making it illegal for health insurers to charge higher premiums to tobacco users, reversing a precedent set by the Affordable Care Act passed in 2010.
Over the last three years, efforts to enshrine a right to contraception have been vetoed by former Governor Youngkin. However, House Bill 6 successfully passed this year with bipartisan support. Most importantly, a statewide referendum on a constitutional amendment enshrining a right to abortion is scheduled for November 3rd, which would effectively prevent future regulation on the practice.
Meanwhile, the General Assembly will be considering revisions proposed by Governor Spanberger to House Bill 483 from April 22nd to 23rd made. The bill would create a Prescription Drug Affordability Advisory Panel which would have the authority to conduct analysis and make recommendations to the government regarding prescription drugs. After a couple years of resistance from Republican lawmakers, the bill gained bipartisan support this year.
A more controversial bill will also create a framework for a retail marijuana market as early as January 1st, 2027. The measure was revised by Governor Spanberger, who argues that the effective date for the framework should be six months later to allow the state more time to finalize the framework. Some Democrat lawmakers have argued that her revisions are too extensive. Lawmakers will consider the changes from April 22nd to 23rd and decide whether to override the Governor’s veto or accept the revisions.
Health care and drug control have been a rare area of bipartisan collaboration and success this year. Meanwhile, health care costs, which remained a central point of debate during the federal government’s negotiations earlier this year, are evidently a field where both parties feel they could directly help citizens. While some of the bills mentioned in this article have not yet been finalized yet, the General Assembly has already made notable changes on these issues.
Leave a Reply